Literature DB >> 25037517

Valve disease in pregnancy.

Cara Pessel1, Clarissa Bonanno2.   

Abstract

Maternal cardiac disease is a major cause of non-obstetric morbidity and accounts for 10-25% of maternal mortality. Valvular heart disease may result from congenital abnormalities or acquired lesions, some of which may involve more than one valve. Maternal and fetal risks in pregnant patients with valve disease vary according to the type and severity of the valve lesion along with resulting abnormalities of functional capacity, left ventricular function, and pulmonary artery pressure. Certain high-risk conditions are considered contraindications to pregnancy, while others may be successfully managed with observation, medications, and, in refractory cases, surgical intervention. Communication between the patient׳s obstetrician, maternal-fetal medicine specialist, obstetrical anesthesiologist, and cardiologist is critical in managing a pregnancy with underlying maternal cardiac disease. The management of the various types of valve diseases in pregnancy will be reviewed here, along with a discussion of related complications including mechanical prosthetic valves and infective endocarditis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic; Cardiac disease; Mitral; Pregnancy; Regurgitation; Stenosis; Valve

Mesh:

Year:  2014        PMID: 25037517     DOI: 10.1053/j.semperi.2014.04.016

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  4 in total

Review 1.  The Use of Echocardiography and Advanced Cardiac Ultrasonography During Pregnancy.

Authors:  Anna C O'Kelly; Garima Sharma; Arthur Jason Vaught; Sammy Zakaria
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-21

2.  Ventricular wall stress and wall shear stress homeostasis predicts cardiac remodeling during pregnancy: A modeling study.

Authors:  Giulia Comunale; Francesca M Susin; Jonathan P Mynard
Journal:  Int J Numer Method Biomed Eng       Date:  2021-10-18       Impact factor: 2.648

3.  Bioprosthetic aortic valve replacement 12 years after percutaneous aortic valvuloplasty in a young female adult with hope of pregnancy.

Authors:  Hirohiko Akutsu; Yuichiro Kaminishi; Soki Kurumisawa; Yoshio Misawa
Journal:  Acute Med Surg       Date:  2016-02-26

4.  Optimal Management of a Pregnant Patient with Rheumatic Heart Disease.

Authors:  J Brendan Mitchelson; Douglas E Cleveland
Journal:  Kans J Med       Date:  2018-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.